🇺🇸 FDA
Patent

US 9127050

Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease

granted A61KA61K2039/505A61K39/00

Quick answer

US patent 9127050 (Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease) held by Regents of the University of Minnesota expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
52
CPC classes
A61K, A61K2039/505, A61K39/00, A61K39/092, A61P